These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30043385)

  • 1. Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project.
    Caster O; Dietrich J; Kürzinger ML; Lerch M; Maskell S; Norén GN; Tcherny-Lessenot S; Vroman B; Wisniewski A; van Stekelenborg J
    Drug Saf; 2018 Dec; 41(12):1355-1369. PubMed ID: 30043385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project.
    Gattepaille LM; Hedfors Vidlin S; Bergvall T; Pierce CE; Ellenius J
    Drug Saf; 2020 Aug; 43(8):797-808. PubMed ID: 32410156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.
    Pierce CE; de Vries ST; Bodin-Parssinen S; Härmark L; Tregunno P; Lewis DJ; Maskell S; Van Eemeren R; Ptaszynska-Neophytou A; Newbould V; Dasgupta N; Wisniewski AFZ; Gama S; Mol PGM
    Drug Saf; 2019 Apr; 42(4):477-489. PubMed ID: 30911975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.
    Pierce CE; Bouri K; Pamer C; Proestel S; Rodriguez HW; Van Le H; Freifeld CC; Brownstein JS; Walderhaug M; Edwards IR; Dasgupta N
    Drug Saf; 2017 Apr; 40(4):317-331. PubMed ID: 28044249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR.
    Dietrich J; Gattepaille LM; Grum BA; Jiri L; Lerch M; Sartori D; Wisniewski A
    Drug Saf; 2020 May; 43(5):467-478. PubMed ID: 31997289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".
    Bousquet C; Audeh B; Bellet F; Lillo-Le Louët A
    Drug Saf; 2018 Dec; 41(12):1371-1373. PubMed ID: 30341678
    [No Abstract]   [Full Text] [Related]  

  • 7. Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions.
    Li Y; Jimeno Yepes A; Xiao C
    Drug Saf; 2020 Sep; 43(9):893-903. PubMed ID: 32385840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe.
    Brosch S; de Ferran AM; Newbould V; Farkas D; Lengsavath M; Tregunno P
    Drug Saf; 2019 Aug; 42(8):921-930. PubMed ID: 30929141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of text processing methods in social media-based signal detection.
    Gavrielov-Yusim N; Kürzinger ML; Nishikawa C; Pan C; Pouget J; Epstein LB; Golant Y; Tcherny-Lessenot S; Lin S; Hamelin B; Juhaeri J
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1309-1317. PubMed ID: 31392844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR.
    van Stekelenborg J; Ellenius J; Maskell S; Bergvall T; Caster O; Dasgupta N; Dietrich J; Gama S; Lewis D; Newbould V; Brosch S; Pierce CE; Powell G; Ptaszyńska-Neophytou A; Wiśniewski AFZ; Tregunno P; Norén GN; Pirmohamed M
    Drug Saf; 2019 Dec; 42(12):1393-1407. PubMed ID: 31446567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.
    Caster O; Aoki Y; Gattepaille LM; Grundmark B
    Drug Saf; 2020 May; 43(5):479-487. PubMed ID: 32008183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factor Considerations in Statistical Signal Detection: Using Subgroup Disproportionality to Uncover Risk Groups for Adverse Drug Reactions in VigiBase.
    Sandberg L; Taavola H; Aoki Y; Chandler R; Norén GN
    Drug Saf; 2020 Oct; 43(10):999-1009. PubMed ID: 32564242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
    Zhou Z; Hultgren KE
    JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.
    Karapetiantz P; Audeh B; Redjdal A; Tiffet T; Bousquet C; Jaulent MC
    J Med Internet Res; 2024 Jun; 26():e46176. PubMed ID: 38888956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social Media Listening for Routine Post-Marketing Safety Surveillance.
    Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N
    Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank.
    Caster O; Juhlin K; Watson S; Norén GN
    Drug Saf; 2014 Aug; 37(8):617-28. PubMed ID: 25052742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media.
    Comfort S; Perera S; Hudson Z; Dorrell D; Meireis S; Nagarajan M; Ramakrishnan C; Fine J
    Drug Saf; 2018 Jun; 41(6):579-590. PubMed ID: 29446035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
    Oosterhuis I; Taavola H; Tregunno PM; Mas P; Gama S; Newbould V; Caster O; Härmark L
    Drug Saf; 2018 Oct; 41(10):969-978. PubMed ID: 29761281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Feasibility Study of Drug-Drug Interaction Signal Detection in Regular Pharmacovigilance.
    Hult S; Sartori D; Bergvall T; Hedfors Vidlin S; Grundmark B; Ellenius J; Norén GN
    Drug Saf; 2020 Aug; 43(8):775-785. PubMed ID: 32681439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.